Who
Matthew Paul Del Giudice
Director
Company insider
Files Form 4 as: Director, MIRA Pharmaceuticals; Director, Telomir Pharmaceuticals.
In numbers
- Trades disclosed
- 11
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 25 Mar 2024
- Last trade
- 12 Jun 2026
- Last filed
- 27 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Jun 2026filed 15 Jun 2026 | MIRA MIRA Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 12 Jun 2026filed 15 Jun 2026 | MIRA MIRA Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | TELO Telomir Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 | filing |
| 21 May 2026filed 22 May 2026 | TELO Telomir Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —25,000 | filing |
| 21 May 2026filed 22 May 2026 | TELO Telomir Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 | filing |
| 21 May 2026filed 22 May 2026 | TELO Telomir Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —25,000 | filing |
| 16 Apr 2026filed 27 Jul 2026 | TELO Telomir Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 16 Apr 2026filed 27 Jul 2026 | TELO Telomir Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 9 Dec 2024filed 10 Dec 2024 | MIRA MIRA Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 27 Aug 2024filed 29 Aug 2024 | TELO Telomir Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 25 Mar 2024filed 27 Mar 2024 | MIRA MIRA Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.